Report: The Pharmaceutical Industry in Japan 2025

About the Report 

Japan has one of the world’s largest pharmaceutical markets, ranking third after the United States and China. In 2024, the market expanded to 11.5 trillion yen, marking the fourth consecutive year of growth.European small- and medium-sized enterprises (SMEs) can explore several business opportunities in Japan’s pharmaceutical sector, particularly in niche markets, partnerships, and advanced technologies.

The purpose of this report is to evaluate the current status of the pharmaceutical industry in Japan. It offers insights into market trends and developments, specifically targeting EU-based small- and mid-sized companies that manufacture drugs. These companies may be looking to enter the Japanese market or strengthen their existing presence in Japan. This report also aims to inform other stakeholders in the value chain, including exporters.

About the Expert

Maths Lundin, founder of Sweden Japan Consulting Co., Ltd. (SJC K.K.) has more than 35 years of business experience in Japan, including sectors such as interim management, home appliances and food service equipment. In 2008, he founded a consulting firm supporting European companies entering the Japanese market.

Click here to watch the related webinar. 

Click the link below to download the report: